{"id":553285,"date":"2026-04-27T22:07:43","date_gmt":"2026-04-27T20:07:43","guid":{"rendered":"https:\/\/medizinonline.com\/?p=553285"},"modified":"2026-04-27T22:07:53","modified_gmt":"2026-04-27T20:07:53","slug":"le-syndrome-metabolique-comme-facteur-de-risque-cardiovasculaire","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/le-syndrome-metabolique-comme-facteur-de-risque-cardiovasculaire\/","title":{"rendered":"Le syndrome m\u00e9tabolique comme facteur de risque cardiovasculaire"},"content":{"rendered":"\n<p><strong>Les donn\u00e9es actuelles de 2025\/2026 le prouvent : 1,54 milliard d&#8217;adultes dans le monde sont concern\u00e9s &#8211; et le risque d&#8217;\u00e9v\u00e9nements cardiovasculaires graves augmente proportionnellement au nombre de composants. Nouvelles preuves sur la physiopathologie, le risque d&#8217;insuffisance cardiaque et la possibilit\u00e9 de traitement. Le syndrome m\u00e9tabolique (MetS) est l&#8217;entit\u00e9 de risque cardiom\u00e9tabolique qui conna\u00eet la plus forte croissance au monde. Une \u00e9tude de mod\u00e9lisation mondiale publi\u00e9e en d\u00e9cembre 2025 dans <em>Nature Communications<\/em> et portant sur des donn\u00e9es provenant de plus de 45 millions d&#8217;adultes chiffre la pr\u00e9valence totale \u00e0 1,54 milliard de personnes, soit un doublement en l&#8217;espace de deux d\u00e9cennies. Le risque de MACE, l&#8217;incidence de l&#8217;insuffisance cardiaque et la mortalit\u00e9 totale augmentent avec l&#8217;augmentation de la charge en composants, dans une relation dose-r\u00e9ponse cliniquement tr\u00e8s pertinente. Parall\u00e8lement, de nouveaux essais fournissent pour la premi\u00e8re fois des preuves que le MetS peut \u00eatre r\u00e9habilit\u00e9 de mani\u00e8re durable sous intervention cibl\u00e9e.     <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fle-syndrome-metabolique-comme-facteur-de-risque-cardiovasculaire%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Les donn\u00e9es actuelles de 2025\/2026 le prouvent : 1,54 milliard d&#8217;adultes dans le monde sont concern\u00e9s &#8211; et le risque d&#8217;\u00e9v\u00e9nements cardiovasculaires graves augmente proportionnellement au nombre de composants. Nouvelles&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fle-syndrome-metabolique-comme-facteur-de-risque-cardiovasculaire%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":553286,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Risque de MACE, incidence de l'insuffisance cardiaque et mortalit\u00e9 totale","footnotes":""},"category":[11378,11404,11527,11531,11315,11549],"tags":[90853,25518,90854,25193],"powerkit_post_featured":[],"class_list":["post-553285","post","type-post","status-publish","format-standard","has-post-thumbnail","category-cardiologie","category-endocrinologie-et-diabetologie","category-etudes","category-formation-continue","category-medecine-interne-generale","category-rx-fr","tag-graisse-viscerale","tag-mace-fr","tag-mets","tag-syndrome-metabolique","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-05 00:52:54","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":553266,"slug":"la-sindrome-metabolica-come-fattore-di-rischio-cardiovascolare","post_title":"La sindrome metabolica come fattore di rischio cardiovascolare","href":"https:\/\/medizinonline.com\/it\/la-sindrome-metabolica-come-fattore-di-rischio-cardiovascolare\/"},"pt_PT":{"locale":"pt_PT","id":553263,"slug":"a-sindrome-metabolica-como-fator-de-risco-cardiovascular","post_title":"A s\u00edndrome metab\u00f3lica como fator de risco cardiovascular","href":"https:\/\/medizinonline.com\/pt-pt\/a-sindrome-metabolica-como-fator-de-risco-cardiovascular\/"},"es_ES":{"locale":"es_ES","id":553267,"slug":"el-sindrome-metabolico-como-factor-de-riesgo-cardiovascular","post_title":"El s\u00edndrome metab\u00f3lico como factor de riesgo cardiovascular","href":"https:\/\/medizinonline.com\/es\/el-sindrome-metabolico-como-factor-de-riesgo-cardiovascular\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/553285","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=553285"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/553285\/revisions"}],"predecessor-version":[{"id":553287,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/553285\/revisions\/553287"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/553286"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=553285"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=553285"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=553285"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=553285"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}